How Lipitor Lowers Cholesterol
Lipitor (atorvastatin) inhibits HMG-CoA reductase, an enzyme in the liver that produces cholesterol. This protein converts HMG-CoA into mevalonate, a key step in the mevalonate pathway for cholesterol synthesis. By blocking it, Lipitor reduces low-density lipoprotein (LDL) cholesterol levels in the blood.[1]
What Happens When HMG-CoA Reductase Is Inhibited
The body responds by upregulating LDL receptors on liver cells, which pull more LDL from the bloodstream, further lowering circulating cholesterol. This mechanism also limits production of other isoprenoids derived from the pathway.[1][2]
Why Target This Specific Protein
HMG-CoA reductase is the rate-limiting enzyme in cholesterol biosynthesis, making it an ideal target for statins like Lipitor. Overactivity contributes to hypercholesterolemia and atherosclerosis risk.[2]
Differences from Other Statins
All statins (e.g., simvastatin, rosuvastatin) target HMG-CoA reductase but vary in potency and binding affinity. Lipitor has high liver selectivity and potency due to its structure.[1][3]
Common Patient Questions on Lipitor's Effects
Patients often ask if it affects muscle proteins—yes, rarely, inhibition can deplete coenzyme Q10, linked to myopathy. Liver enzyme monitoring is standard.[2]
[1]: DrugPatentWatch.com - Atorvastatin Patents and Mechanism
[2]: FDA Label - Lipitor
[3]: PubMed - Statin Mechanisms Review